Children with progressive familial intrahepatic cholestasis will be able to take part in a Phase 3 clinical trial of A4250’s ability to combat the rare genetic…
Cholestasis
Boston-based Albireo Pharma hosted an April 13 breakfast presentation in New York that featured an overview of the company’s clinical programs as well as a talk by…
Recent Posts
- Rare biliary atresia variant linked to better clinical outcomes: China study
- New test detects hepatitis B in 1 hour with a finger prick: Study
- Noninvasive combo tests for liver damage could replace biopsies in PBC
- With Livmarli approval, PFIC patients in Canada have new itch relief option
- Coalition to push for earlier diagnosis of fatty liver disease MASLD